BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 37182313)

  • 1. Mitochondrial remodeling in colorectal cancer initiation, progression, metastasis, and therapy: A review.
    Abdelmaksoud NM; Abulsoud AI; Abdelghany TM; Elshaer SS; Rizk SM; Senousy MA
    Pathol Res Pract; 2023 Jun; 246():154509. PubMed ID: 37182313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA: A new player in response to therapy for colorectal cancer.
    Sarvizadeh M; Malekshahi ZV; Razi E; Sharifi H; Moussavi N; Taghizadeh M
    J Cell Physiol; 2019 Jun; 234(6):8533-8540. PubMed ID: 30478837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of Non-coding RNAs in the Signaling Pathways of Colorectal Cancer.
    Yang Y; Du Y; Liu X; Cho WC
    Adv Exp Med Biol; 2016; 937():19-51. PubMed ID: 27573893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanisms and clinical uses of miRNAs in colorectal cancer].
    Ogawa Y; Mimori K
    Nihon Rinsho; 2016 Nov; 74(11):1807-1811. PubMed ID: 30550686
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of microRNAs in 5-FU resistance of colorectal cancer: Possible mechanisms.
    Marjaneh RM; Khazaei M; Ferns GA; Avan A; Aghaee-Bakhtiari SH
    J Cell Physiol; 2019 Mar; 234(3):2306-2316. PubMed ID: 30191973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Dual Role of MicroRNAs in Colorectal Cancer Progression.
    Ding L; Lan Z; Xiong X; Ao H; Feng Y; Gu H; Yu M; Cui Q
    Int J Mol Sci; 2018 Sep; 19(9):. PubMed ID: 30227605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic pathways regulating colorectal cancer initiation and progression.
    La Vecchia S; Sebastián C
    Semin Cell Dev Biol; 2020 Feb; 98():63-70. PubMed ID: 31129171
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Pathways Regulating Colorectal Cancer: A Potential Therapeutic Approach.
    Zafari N; Velayati M; Damavandi S; Pourali G; Mobarhan MG; Nassiri M; Hassanian SM; Khazaei M; Ferns GA; Avan A
    Curr Pharm Des; 2022; 28(36):2995-3009. PubMed ID: 36154599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNAs as novel predictive biomarkers and therapeutic targets in colorectal cancer.
    Stiegelbauer V; Perakis S; Deutsch A; Ling H; Gerger A; Pichler M
    World J Gastroenterol; 2014 Sep; 20(33):11727-35. PubMed ID: 25206276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitochondria and cancer chemoresistance.
    Guerra F; Arbini AA; Moro L
    Biochim Biophys Acta Bioenerg; 2017 Aug; 1858(8):686-699. PubMed ID: 28161329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exosome-encapsulated miRNAs contribute to CXCL12/CXCR4-induced liver metastasis of colorectal cancer by enhancing M2 polarization of macrophages.
    Wang D; Wang X; Si M; Yang J; Sun S; Wu H; Cui S; Qu X; Yu X
    Cancer Lett; 2020 Apr; 474():36-52. PubMed ID: 31931030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dissecting miRNA signature in colorectal cancer progression and metastasis.
    Huang X; Zhu X; Yu Y; Zhu W; Jin L; Zhang X; Li S; Zou P; Xie C; Cui R
    Cancer Lett; 2021 Mar; 501():66-82. PubMed ID: 33385486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Emerging Role of MitomiRs in the Pathophysiology of Human Disease.
    Duarte FV; Palmeira CM; Rolo AP
    Adv Exp Med Biol; 2015; 888():123-54. PubMed ID: 26663182
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disruption of the c-Myc/miR-200b-3p/PRDX2 regulatory loop enhances tumor metastasis and chemotherapeutic resistance in colorectal cancer.
    Lv Z; Wei J; You W; Wang R; Shang J; Xiong Y; Yang H; Yang X; Fu Z
    J Transl Med; 2017 Dec; 15(1):257. PubMed ID: 29258530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Updated Review of the Pre-Clinical Role of microRNAs and their Contribution to Colorectal Cancer.
    Dastmalchi N; Safaralizadeh R; Teimourian S
    Curr Mol Med; 2022; 22(10):851-859. PubMed ID: 34961460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incomplete cellular reprogramming of colorectal cancer cells elicits an epithelial/mesenchymal hybrid phenotype.
    Hiew MSY; Cheng HP; Huang CJ; Chong KY; Cheong SK; Choo KB; Kamarul T
    J Biomed Sci; 2018 Jul; 25(1):57. PubMed ID: 30025541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. miRNAs as cornerstones in colorectal cancer pathogenesis and resistance to therapy: A spotlight on signaling pathways interplay - A review.
    Elrebehy MA; Al-Saeed S; Gamal S; El-Sayed A; Ahmed AA; Waheed O; Ismail A; El-Mahdy HA; Sallam AM; Doghish AS
    Int J Biol Macromol; 2022 Aug; 214():583-600. PubMed ID: 35768045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic miRNAs and target therapies in colorectal cancer.
    Saberinia A; Alinezhad A; Jafari F; Soltany S; Akhavan Sigari R
    Clin Chim Acta; 2020 Sep; 508():77-91. PubMed ID: 32407782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insights into the Role of microRNAs in Colorectal Cancer (CRC) Metabolism.
    Wai Hon K; Zainal Abidin SA; Othman I; Naidu R
    Cancers (Basel); 2020 Aug; 12(9):. PubMed ID: 32878019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
    Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
    Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.